Although some studies have evaluated the effectiveness of imatinib and sunitinib in STS other than GIST [17], [18] only little is known regarding the effectiveness of nilotinib and whether a combination of TK inhibitors with conventional chemotherapy may improve treatment outcome for this type of solid tumors. The gene discussed is TKT; the disease is gastrointestinal stromal tumor.